Growth Stocks
Companies worth $1 billion or more whose revenue has grown at least 20% a year over the last three fiscal years.
Stocks matching the screen
Data as of the October 26, 2026 close| IOVAIovance Biotherapeutics, Inc. | Iovance Biotherapeutics, Inc. | $6.24B | +65.7% | 0.00% | +934% | — | — | — |
| BBNXBeta Bionics, Inc. | Beta Bionics, Inc. | $1.11B | +37.8% | 0.00% | +724% | — | — | — |
| IBRXImmunityBio, Inc. | ImmunityBio, Inc. | $8.28B | +93.9% | 0.00% | +679% | +185% | — | — |
| CRWVCoreWeave, Inc. | CoreWeave, Inc. | $30.40B | +112% | 0.00% | +587% | — | — | — |
| TGTXTG Therapeutics, Inc. | TG Therapeutics, Inc. | $8.39B | +70.3% | −70.6% | +505% | +427% | — | — |
| QXOQXO, Inc. | QXO, Inc. | $10.90B | +70.3% | 0.00% | +434% | +178% | — | — |
| ARQTArcutis Biotherapeutics, Inc. | Arcutis Biotherapeutics, Inc. | $4.00B | +59.3% | 0.00% | +367% | — | — | — |
| CIFRCipher Mining Inc. | Cipher Mining Inc. | $3.19B | −43.0% | +19.5% | +319% | — | — | — |
| VRDNViridian Therapeutics, Inc. | Viridian Therapeutics, Inc. | $2.64B | +279% | 0.00% | +242% | +132% | — | — |
| NBISNebius Group N.V. | Nebius Group N.V. | $41.70B | +454% | 0.00% | +240% | −29.0% | — | — |
| CHAChagee Holdings Limited American Depositary Shares | Chagee Holdings Limited American Depositary Shares | $2.37B | +2.50% | +591% | +197% | — | — | — |
| ONDSOndas Holdings Inc. | Ondas Holdings Inc. | $3.44B | — | 0.00% | +188% | +87.9% | — | — |
| ANABAnaptysBio, Inc. | AnaptysBio, Inc. | $1.46B | +23.5% | 0.00% | +184% | +25.6% | — | — |
| CGONCG Oncology, Inc. | CG Oncology, Inc. | $5.46B | — | 0.00% | +177% | — | — | — |
| CBRSCerebras Systems Inc. | Cerebras Systems Inc. | $25.70B | +74.3% | 0.00% | +175% | — | — | — |
| UROYUranium Royalty Corp. | Uranium Royalty Corp. | $1.30B | +113% | — | +165% | — | — | — |
| TARSTarsus Pharmaceuticals, Inc. | Tarsus Pharmaceuticals, Inc. | $3.28B | +69.4% | 0.00% | +160% | +68.3% | — | — |
| ASSTStrive, Inc. | Strive, Inc. | $2.66B | +94.6% | 0.00% | +156% | +131% | — | — |
| AMPXAmprius Technologies, Inc. | Amprius Technologies, Inc. | $1.22B | +126% | 0.00% | +155% | +73.2% | — | — |
| MESOMesoblast Limited | Mesoblast Limited | $1.61B | +391% | 0.00% | +152% | +74.5% | — | — |
| EFCEllington Financial Inc. | Ellington Financial Inc. | $1.54B | +33.8% | −3.30% | +150% | +84.8% | +3.70% | +2.70% |
| STOKStoke Therapeutics, Inc. | Stoke Therapeutics, Inc. | $1.64B | −32.5% | 0.00% | +146% | — | — | — |
| BMNRBitMine Immersion Technologies, Inc. | BitMine Immersion Technologies, Inc. | $12.60B | — | 0.00% | +142% | — | — | — |
| ASNDAscendis Pharma A/S | Ascendis Pharma A/S | $16.10B | +115% | 0.00% | +138% | +151% | — | — |
| AXSMAxsome Therapeutics, Inc. | Axsome Therapeutics, Inc. | $7.55B | +45.5% | 0.00% | +134% | — | — | — |
| KMTSKestra Medical Technologies, Ltd. | Kestra Medical Technologies, Ltd. | $1.75B | +59.9% | 0.00% | +132% | — | — | — |
| SLFSun Life Financial Inc. | Sun Life Financial Inc. | $44.20B | +7.50% | +43.2% | +131% | −0.50% | +0.80% | +3.20% |
| IONQIonQ, Inc. | IonQ, Inc. | $12.50B | +287% | 0.00% | +127% | +291% | — | — |
| WULFTeraWulf Inc. | TeraWulf Inc. | $5.98B | −6.00% | 0.00% | +124% | +65.8% | — | — |
| RLAYRelay Therapeutics, Inc. | Relay Therapeutics, Inc. | $3.97B | −48.3% | 0.00% | +123% | −28.6% | — | — |
| APLDApplied Digital Corporation | Applied Digital Corporation | $5.39B | +322% | 0.00% | +123% | — | — | — |
| ALABAstera Labs, Inc. | Astera Labs, Inc. | $45.00B | +104% | +186% | +120% | — | — | — |
| YPFYPF Sociedad Anónima | YPF Sociedad Anónima | $19.30B | +72.2% | — | +119% | +407% | — | — |
| ARGXargenx SE | argenx SE | $54.70B | +59.3% | +95.2% | +116% | +152% | — | — |
| LQDALiquidia Corporation | Liquidia Corporation | $3.92B | — | 0.00% | +115% | +192% | — | — |
| IRENIris Energy Limited | Iris Energy Limited | $10.00B | −26.7% | +42.9% | +111% | +160% | — | — |
| LEGNLegend Biotech Corporation | Legend Biotech Corporation | $3.97B | +51.9% | 0.00% | +106% | +68.8% | — | — |
| MUMicron Technology, Inc. | Micron Technology, Inc. | $1.02T | +379% | — | +105% | +36.9% | — | +65.5% |
| CRSPCRISPR Therapeutics AG | CRISPR Therapeutics AG | $4.74B | — | 0.00% | +100% | +37.3% | — | — |
| SBETSharpLink Gaming Ltd. | SharpLink Gaming Ltd. | $1.56B | — | 0.00% | +100% | +65.2% | — | — |
| RYTMRhythm Pharmaceuticals, Inc. | Rhythm Pharmaceuticals, Inc. | $6.14B | +46.9% | 0.00% | +100% | +458% | — | — |
| NVDANVIDIA Corporation | NVIDIA Corporation | $5.22T | +106% | +128% | +100% | +66.9% | +143% | +80.4% |
| MARAMarathon Digital Holdings, Inc. | Marathon Digital Holdings, Inc. | $2.64B | −26.7% | +86.7% | +97.5% | +191% | — | — |
| OCSLOaktree Specialty Lending Corporation | Oaktree Specialty Lending Corporation | $1.01B | −7.80% | −19.3% | +97.1% | +41.8% | −5.70% | +1.30% |
| TLXTelix Pharmaceuticals Limited | Telix Pharmaceuticals Limited | $3.05B | +22.3% | 0.00% | +96.0% | +197% | — | — |
| CRDOCredo Technology Group Holding Ltd | Credo Technology Group Holding Ltd | $28.40B | +115% | +97.1% | +93.5% | +86.8% | +285% | — |
| ALVOAlvotech | Alvotech | $1.65B | −38.9% | −99.0% | +91.9% | +54.5% | — | — |
| KRSAKorsana Biosciences, Inc. | Korsana Biosciences, Inc. | $1.46B | 0.00% | 0.00% | +91.1% | −2.00% | — | — |
| MIRMMirum Pharmaceuticals, Inc. | Mirum Pharmaceuticals, Inc. | $5.41B | +37.9% | 0.00% | +89.1% | +116% | — | — |
| VFSVinFast Auto Ltd. | VinFast Auto Ltd. | $7.06B | +41.7% | 0.00% | +86.6% | +45.9% | — | — |
End-of-day prices and company fundamentals from EODHD. Fundamentals are refreshed after each earnings report. Ratios that are negative or not meaningful are shown as —. For information only, not investment advice.
Screening criteria
- Revenue growth of 20% or more a year over the last 3 fiscal years (CAGR)
- Market cap of $1 billion or more
Common stocks and ADRs on the NYSE, Nasdaq and NYSE American; ETFs, OTC stocks and halted stocks excluded. Change or add filters above to refine the list; the full stock screener has more than 60 filters.
About this screen
Growth stocks are companies whose sales and earnings grow much faster than the economy. This screen uses the compound annual growth rate (CAGR) of revenue over three fiscal years, which smooths out a single unusually strong or weak year.
Fast growth often comes with high valuations and, for younger companies, losses. Check profitability and valuation in the other tabs, and the quarterly revenue growth for a more recent view.
Growth Stocks FAQ
Which US companies are growing revenue the fastest?
As of the October 26, 2026 close, 481 companies with a market cap above $1 billion had grown revenue by 20% or more a year over three years. The fastest growth was at Iovance Biotherapeutics, Inc. (IOVA), Beta Bionics, Inc. (BBNX) and ImmunityBio, Inc. (IBRX).
What is CAGR?
The compound annual growth rate is the steady yearly rate that would take revenue from its level three years ago to its level today. Revenue rising from $100 million to $200 million in three years is a CAGR of about 26%.
Are growth stocks risky?
They can be more volatile, because their prices depend on growth continuing. If growth slows, high valuations can fall quickly.
Other stock screens
- Stock Screener (all filters)
- Dividend Stocks
- High Dividend Yield Stocks
- Dividend Growth Stocks
- Value Stocks
- Penny Stocks
- Stocks at 52-Week Highs
- Stocks at 52-Week Lows
- Oversold Stocks
- Overbought Stocks
- Most Shorted Stocks
- Strong Buy Stocks
- Stocks With the Highest Upside
- Golden Cross Stocks
- All US Stocks List